Avestar Capital, LLC Charles River Laboratories International, Inc. Transaction History

Avestar Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$203.52 - $273.43 $8,954 - $12,030	-44 Reduced 3.31%	1,287 $348,000
Q4 2023 Feb 12, 2024	SELL	$164.52 - $238.84 $19,577 - $28,421	-119 Reduced 8.21%	1,331 $314,000
Q3 2023 Oct 20, 2023	BUY	$194.44 - $217.61 $3,305 - $3,699	17 Added 1.19%	1,450 $284,000
Q2 2023 Aug 01, 2023	BUY	$183.71 - $210.25 $263,256 - $301,288	1,433 New	1,433 $301,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.